Australia - English - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - tetracosactide, quantity: 0.25 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; acetic acid; sodium acetate - indications as at 12 august 1999: as a diagnostic aid in the assessment of suspected adrenocortical hypofunction.

Canada - English - Health Canada

amphastar pharmaceuticals, inc. - tetracosactide - powder for solution - 0.25mg - tetracosactide 0.25mg - adrenocortical insufficiency

Canada - English - Health Canada

dechra ltd - tetracosactide - solution - 0.25mg - tetracosactide 0.25mg - dogs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

dechra regulatory bv - tetracosactide - solution for injection - hormone - dogs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

dechra limited - tetracosactide - solution for injection - hormone - dogs

Israel - English - Ministry of Health

novartis pharma services ag - tetracosactide hexaacetate 1 mg/ml - suspension for injection - tetracosactide - collagen diseases, neurological diseases, chronic skin disorders.

Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

yousif mahmood hussain & bahrain pharmacy co - tetracosactide hexaacetate - suspension for injection - 1

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

novartis - tetracosactide - suspension for injection - 1 mg/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

mallinckrodt specialty pharmaceuticals, ireland - tetracosactide (tetracosactrin) - injection - 1 mg/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

atnahs pharma uk limited, united kingdom - tetracosactide - suspension for injection - 1 mg/ml